Publication: Next-generation sequencing analysis reveals that MTH-3, a novel curcuminoid derivative, suppresses the invasion of MDA-MB-231 triple-negative breast adenocarcinoma cells
| cris.lastimport.scopus | 2026-02-27T16:02:14Z | |
| dc.creator | Chiu, Yu-Jen | |
| dc.creator | Tsai, Fuu-Jen | |
| dc.creator | Bau, Da-Tian | |
| dc.creator | Chang, Ling-Chu | |
| dc.creator | Hsieh, Min-Tsang | |
| dc.creator | Lu, Chi-Cheng | |
| dc.creator | Kuo, Sheng-Chu | |
| dc.creator | Yang, Jai-Sing | |
| dc.date | 2021-07 | |
| dc.date.accessioned | 2021-11-08T01:36:52Z | |
| dc.date.accessioned | 2025-07-27T15:03:10Z | |
| dc.date.available | 2021-11-08T01:36:52Z | |
| dc.date.issued | 2021-11-08T01:36:52Z | |
| dc.description.abstract | Triple-negative breast cancer (TNBC) behaves aggressively in the invasive and metastatic states. Our research group recently developed a novel curcumin derivative, (1E,3Z,6E)-3-hydroxy-5-oxohepta-1,3,6-triene-1,7-diyl)bis(2-methoxy-4,1-phenylene)bis(3-hydroxy-2-hydroxymethyl)-2-methyl propanoate (MTH-3), and previous studies showed that MTH-3 inhibits TNBC proliferation and induces apoptosis in vitro and in vivo with a superior bioavailability and absorption than curcumin. In the present study, the effects of MTH-3 on TNBC cell invasion were examined using various assays and gelatin zymography, and western blot analysis. Treatment with MTH-3 inhibited MDA-MB-231 cell invasion and migration, as shown by Transwell assay, 3D spheroid invasion assay, and wound healing assay. The results of the gelatin zymography experiments revealed that MTH-3 decreased matrix metalloproteinase-9 activity. The potential signaling pathways were revealed by next-generation sequencing analysis, antibody microarray analysis and western blot analysis. In conclusion, the results of the present study show that, MTH-3 inhibited tumor cell invasion through the MAPK/ERK/AKT signaling pathway and cell cycle regulatory cascade, providing significant information about the potential molecular mechanisms of the effects of MTH-3 on TNBC. | |
| dc.format.extent | 123 bytes | |
| dc.format.mimetype | text/html | |
| dc.identifier.doi | 10.3892/or.2021.8084 | |
| dc.identifier.issn | 1021-335X | |
| dc.identifier.uri | https://ir.ntus.edu.tw/handle/987654321/64469 | |
| dc.language | en_US | |
| dc.publisher | ATHENS, GREECE: SPANDIDOS | |
| dc.relation | ONCOLOGY REPORTS, 46(1) | |
| dc.subject | curcuminoid derivative | |
| dc.subject | triple-negative breast cancer (TNBC) | |
| dc.subject | anti-metastasis | |
| dc.subject | MTH-3 | |
| dc.subject | next generation sequencing analysis | |
| dc.title | Next-generation sequencing analysis reveals that MTH-3, a novel curcuminoid derivative, suppresses the invasion of MDA-MB-231 triple-negative breast adenocarcinoma cells | |
| dc.type | article | |
| dspace.entity.type | Publication |